Cargando…
Corrigendum: A Novel Mechanism of Carvedilol Efficacy for Rosacea Treatment: Toll-Like Receptor 2 Inhibition in Macrophages
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964351/ https://www.ncbi.nlm.nih.gov/pubmed/35371112 http://dx.doi.org/10.3389/fimmu.2022.881277 |
_version_ | 1784678196719910912 |
---|---|
author | Zhang, Jiawen Jiang, Peiyu Sheng, Lei Liu, Yunyi Liu, Yixuan Li, Min Tao, Meng Hu, Liang Wang, Xiaoyan Yang, Yanjing Xu, Yang Liu, Wentao |
author_facet | Zhang, Jiawen Jiang, Peiyu Sheng, Lei Liu, Yunyi Liu, Yixuan Li, Min Tao, Meng Hu, Liang Wang, Xiaoyan Yang, Yanjing Xu, Yang Liu, Wentao |
author_sort | Zhang, Jiawen |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8964351 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-89643512022-03-31 Corrigendum: A Novel Mechanism of Carvedilol Efficacy for Rosacea Treatment: Toll-Like Receptor 2 Inhibition in Macrophages Zhang, Jiawen Jiang, Peiyu Sheng, Lei Liu, Yunyi Liu, Yixuan Li, Min Tao, Meng Hu, Liang Wang, Xiaoyan Yang, Yanjing Xu, Yang Liu, Wentao Front Immunol Immunology Frontiers Media S.A. 2022-03-14 /pmc/articles/PMC8964351/ /pubmed/35371112 http://dx.doi.org/10.3389/fimmu.2022.881277 Text en Copyright © 2022 Zhang, Jiang, Sheng, Liu, Liu, Li, Tao, Hu, Wang, Yang, Xu and Liu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Zhang, Jiawen Jiang, Peiyu Sheng, Lei Liu, Yunyi Liu, Yixuan Li, Min Tao, Meng Hu, Liang Wang, Xiaoyan Yang, Yanjing Xu, Yang Liu, Wentao Corrigendum: A Novel Mechanism of Carvedilol Efficacy for Rosacea Treatment: Toll-Like Receptor 2 Inhibition in Macrophages |
title | Corrigendum: A Novel Mechanism of Carvedilol Efficacy for Rosacea Treatment: Toll-Like Receptor 2 Inhibition in Macrophages |
title_full | Corrigendum: A Novel Mechanism of Carvedilol Efficacy for Rosacea Treatment: Toll-Like Receptor 2 Inhibition in Macrophages |
title_fullStr | Corrigendum: A Novel Mechanism of Carvedilol Efficacy for Rosacea Treatment: Toll-Like Receptor 2 Inhibition in Macrophages |
title_full_unstemmed | Corrigendum: A Novel Mechanism of Carvedilol Efficacy for Rosacea Treatment: Toll-Like Receptor 2 Inhibition in Macrophages |
title_short | Corrigendum: A Novel Mechanism of Carvedilol Efficacy for Rosacea Treatment: Toll-Like Receptor 2 Inhibition in Macrophages |
title_sort | corrigendum: a novel mechanism of carvedilol efficacy for rosacea treatment: toll-like receptor 2 inhibition in macrophages |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964351/ https://www.ncbi.nlm.nih.gov/pubmed/35371112 http://dx.doi.org/10.3389/fimmu.2022.881277 |
work_keys_str_mv | AT zhangjiawen corrigendumanovelmechanismofcarvedilolefficacyforrosaceatreatmenttolllikereceptor2inhibitioninmacrophages AT jiangpeiyu corrigendumanovelmechanismofcarvedilolefficacyforrosaceatreatmenttolllikereceptor2inhibitioninmacrophages AT shenglei corrigendumanovelmechanismofcarvedilolefficacyforrosaceatreatmenttolllikereceptor2inhibitioninmacrophages AT liuyunyi corrigendumanovelmechanismofcarvedilolefficacyforrosaceatreatmenttolllikereceptor2inhibitioninmacrophages AT liuyixuan corrigendumanovelmechanismofcarvedilolefficacyforrosaceatreatmenttolllikereceptor2inhibitioninmacrophages AT limin corrigendumanovelmechanismofcarvedilolefficacyforrosaceatreatmenttolllikereceptor2inhibitioninmacrophages AT taomeng corrigendumanovelmechanismofcarvedilolefficacyforrosaceatreatmenttolllikereceptor2inhibitioninmacrophages AT huliang corrigendumanovelmechanismofcarvedilolefficacyforrosaceatreatmenttolllikereceptor2inhibitioninmacrophages AT wangxiaoyan corrigendumanovelmechanismofcarvedilolefficacyforrosaceatreatmenttolllikereceptor2inhibitioninmacrophages AT yangyanjing corrigendumanovelmechanismofcarvedilolefficacyforrosaceatreatmenttolllikereceptor2inhibitioninmacrophages AT xuyang corrigendumanovelmechanismofcarvedilolefficacyforrosaceatreatmenttolllikereceptor2inhibitioninmacrophages AT liuwentao corrigendumanovelmechanismofcarvedilolefficacyforrosaceatreatmenttolllikereceptor2inhibitioninmacrophages |